ARCHIVES

New Drug for Lymphoma Enters Phase II Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 5 | May 28, 2004

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: PAs Available.

January 28, 2005

Human Genome Consortium Completes “Working Draft”.

June 30, 2000

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

June 17, 1977

In Brief: Treatment Reorganization Plan Due In November, Rauscher Says; Panel To Review Clinical Activities

June 27, 1975

Davis Denies “Cherry-Picking” Data To Support Her Claims.

August 1, 2008